İçeriğe geç
TR

Küresel

Güneydoğu Asya

Latin Amerika

Orta Doğu ve Güney Asya

BIOSPHERE-AITek bir tesis. Doğu misyonu.
İnquiry başlat

Knowledge graph

人参(根)提取物

原料Machine-extracted人参根提取物，化妆品原料

Back to graph

Arama yalnızca Çince ve İngilizceyi kapsar — lütfen İngilizce bir terim veya INCI adı kullanın.

Two sources, labelled separately on every card. Entries marked "From classical texts" come from public-domain Chinese medical classics; herbs are listed without dosages and compositions follow the common editions. Entries marked "Machine-extracted" are derived by a model from BIOSPHERE own-corpus material (formulation library, ingredient dossiers, compliance index, product catalogue). Neither is an efficacy claim or regulatory text — regulatory and safety conclusions follow the official texts and third-party test reports.

From classical textsSite dossierMachine-extractedA hyperedgeTap a circle to open that entity. Drag to pan, wheel or +/- to zoom. A square is one hyperedge joined to all of its participants.

Relations it takes part in

  1. 成分组成Machine-extracted7 participants

    人参提取物-成分组成

    人参提取物主要含人参皂苷(以Rg1、Re、Rb1组合为特征)及多糖、多酚伴生物

  2. 配伍禁忌Machine-extracted7 participants

    人参提取物-配伍禁忌

    1)皂苷表面活性降低界面张力，在W/O或高油相体系里可能削弱乳化稳定性；2)与阳离子调理剂形成复合物，清洁体系泡沫质量下降、粘度掉；3)与高浓度电解质共存时溶解度下降；4)多酚伴生物遇铁离子变色；5)醇溶规格兑水稀释时出现瞬时浑浊

  3. 法规收录Machine-extracted4 participants

    人参提取物-法规收录

    需核对收录状态与使用部位并按目标市场规则复核；欧盟属常规使用方向需完成安全评估并复核限制清单

  4. 植物来源区分Machine-extracted4 participants

    三七与人生区分

    人参与人参同属不同种，成分谱不通用：人参以Rg1/Re/Rb1特定比例组合为特征，三七以三七皂苷R1与Rb1/Rg1为特征，标示物和检测方法不同，不可互换

  5. 稳定性风险Machine-extracted3 participants

    人参提取物-稳定性问题

    高温长时间保温使部分皂苷水解；含糖类与皂苷的提取物是微生物良好碳源，防腐挑战必须单独验证，不能沿用不含人参版本的历史数据

  6. 工艺风险Machine-extracted2 participants

    人参提取物-起泡问题

    起泡是最大工程问题：溶解时禁止高剪切均质头直接打溶液，需低转速搅拌加抽真空；泡沫导致液位假高计量不准、灌装不足、瓶内气泡判外观不良；需静置4-12小时或脱气工序

Want to know how one of these relations plays out in your target market? Send us the formulation direction. Send an inquiry